| Ytd | 61.94% | |
| 1y | 201.56% |
| Open | 40.50 | Prev Close | 40.50 | Low | 40.50 | High | 40.50 | Mkt Cap | 6.27B |
| Vol | 0.00 | Avg Vol | 2.15M | EPS | -1.79 | P/E | -22.75 | Forward P/E | -22.75 |
| Beta | 1.12 | Short Ratio | 1.35 | Inst. Own | 96.93% | Dividend | 38.00 | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 39.77 | 200-d Avg | 29.97 | 1yr Est | 40.25 |
CNTA News
Vancouver, British Columbia--(Newsfile Corp. - July 27, 2026) - Global UAV Technologies Ltd. (CSE: U
BOSTON and LONDON, June 22, 2026 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a
Proven Chief Medical Officer at several publicly listed and clinical-stage oncology companies with s
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
B. Metzler seel. Sohn and Co. AG purchased a new position in Centessa Pharmaceuticals PLC Sponsored
Pre-Market Stock Futures: Futures are trading lower this morning after negotiations with Iran failed
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Centessa (NASDAQ: CNTA) for
Major M&A deals this week include: Eli Lilly's $7.8 billion purchase of Centessa Pharmaceuti
Wall Street analysts changed outlook on top names. Dine Brands, Akamai Tech, Centessa Pharma, Methan
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ: CNTA - Get Free Report)'s stock price hit a new
NEW YORK, April 1, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & As
Lilly is set to acquire Centessa for up to $7.8B, adds sleep disorder drugs and advances its push to
Pre-Market Stock Futures: Futures are trading higher after an explosive rally on Tuesday, sparked by
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
Centessa possesses a promising sleep medicine pipeline. The clinical-stage company's experimental th
Lilly to gain ownership of Centessa's OX2R agonist pipeline designed to improve outcomes across slee
Centessa Pharmaceuticals PLC (NASDAQ:CNTA) shares are surging today, last seen 44.4% higher to trade
U.S. stocks bounce sharply on Tuesday as lower Treasury yields and Trump's signals of a potentia
Eli Lilly has agreed to acquire Centessa Pharmaceuticals in a deal valued at up to $7.8 billion, mar
US stocks rise on Tuesday, with NASDAQ up 2% and Dow up 1.37%. Communication services shares gain 2.
Top Wall Street analysts changed outlook on top names. Needham downgrades CNTA, Baird downgrades PHR
MILWAUKEE, March 31, 2026 /PRNewswire/ -- LLP is investigating Centessa (NASDAQ: CNTA) for possible
Stocks are higher but all three major indexes are on track for monthly and quarterly losses
Eli Lilly to acquire Centessa Pharmaceuticals for $6.3B. CNTA stock surges 45% as Lilly expands its
US stocks rise, Dow Jones gains 600+ pts. Apellis Pharma shares surge 136.4% after buyout by Biogen
Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 100 points on Friday. Shares of
U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here ar
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed
During Friday's trading, 69 companies set new 52-week lows.
During the Thursday's session, 100 stocks hit new 52-week lows.
On Monday, 149 companies reached new 52-week lows.
On Monday, 198 companies reached new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.
On Monday, 524 stocks hit new 52-week lows.
On Thursday, 615 stocks hit new 52-week lows.